Advancing innovations that benefit patients
Thank you for joining us!
2025 Translational Resource Center Networking Exchange: Advancing Bio-Innovations that Benefit Patients
We’re thrilled to announce the successful conclusion of 2025 TRC Networking Exchange!
A big thank you to all our guests, speakers, panelists, moderators, Sponsors, and Friends who made this event truly impactful. Your energy and engagement helped us create meaningful connections and advance our shared goal of driving innovation and clinical translation at the intersection of dental, oral, and craniofacial research and regenerative medicine.
What is the Translational Resource Center?
The “Translational Resource Center”, formerly known as the Michigan-Pittsburgh-Wyss Regenerative Medicine Resource Center, is one of the two national Resource Centers established by the National Institute of Dental and Craniofacial Research (NIDCR)’s Dental Oral and Craniofacial Tissue Regeneration Consortium (DOCTRC) initiative, under award numbers U24DE026915 & U24DE029462. With the overarching goal of developing clinical trial-ready tissue engineering/ regenerative medicine products and protocols, the DOCTRC initiative provides funding and resources through the Interdisciplinary Translational Project (ITP) program administered by the two national Resource Centers.
The Translational Resource Center brings together a multi-disciplinary team of clinicians, engineers, scientists, and technology commercialization and regulatory experts from academia and industry. This team supports the regenerative medicine research community by providing resources and expertise to guide innovations that address unmet clinical needs for the regeneration or restoration of DOC tissues. Through its Core Services and Resources, the Translational Resource Center strives to accelerate the translation of promising technologies towards clinical trials and beyond.
Collective Impact
With funding from the National Institute of Dental and Cranial Research (NIDCR), TRC brings together a multidisciplinary team from academia and industry to support the regenerative medicine research community, guide technologies towards FDA submission, and address unmet clinical needs.
At the heart of the TRC is the Interdisciplinary Translational Project (ITP) program, dedicated to shepherding promising regenerative technologies that address unmet clinical needs in dental, oral, and craniofacial healthcare. With the key metric of FDA clearances/ approvals, experts throughout the TRC provide essential translational expertise, guiding projects from research phase through preclinical development, supporting the crucial steps toward FDA submission, always with clinical adoption in mind.
To date, the TRC and its ITP teams have achieved remarkable milestones:
